Assembly Biosciences Inc (ASMB) is now in the Overvalued zone, suggesting that its current forward PS ratio of 17.60 is considered Overvalued compared with the five-year average of -2.36. The fair price of Assembly Biosciences Inc (ASMB) is between 7.15 to 23.15 according to relative valuation method. Compared to the current price of 29.68 USD , Assembly Biosciences Inc By Overvalued By 28.19%.

Relative Value

Fair Zone

7.15-23.15

Current Price：29.68

28.19%

Overvalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Assembly Biosciences Inc (ASMB) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Assembly Biosciences Inc (ASMB) has a current Price-to-Book (P/B) ratio of 2.92. Compared to its 3-year average P/B ratio of 2.79, the current P/B ratio is approximately 4.76% higher. Relative to its 5-year average P/B ratio of 1.90, the current P/B ratio is about 53.72% higher. Assembly Biosciences Inc (ASMB) has a Forward Free Cash Flow (FCF) yield of approximately -10.45%. Compared to its 3-year average FCF yield of -41.41%, the current FCF yield is approximately -74.76% lower. Relative to its 5-year average FCF yield of -59.91%, the current FCF yield is about -82.56% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for ASMB competitors is 7.71, providing a benchmark for relative valuation. Assembly Biosciences Inc Corp (ASMB.O) exhibits a P/S ratio of 17.60, which is 128.33% above the industry average. Given its robust revenue growth of 57.62%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of ASMB increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of ASMB in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is ASMB currently overvalued or undervalued?

Assembly Biosciences Inc (ASMB) is now in the Overvalued zone, suggesting that its current forward PS ratio of 17.60 is considered Overvalued compared with the five-year average of -2.36. The fair price of Assembly Biosciences Inc (ASMB) is between 7.15 to 23.15 according to relative valuation method. Compared to the current price of 29.68 USD, Assembly Biosciences Inc is Overvalued By 28.19%.

What is Assembly Biosciences Inc (ASMB) fair value?

ASMB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Assembly Biosciences Inc (ASMB) is between 7.15 to 23.15 according to relative valuation method.

How does ASMB's valuation metrics compare to the industry average?

The average P/S ratio for ASMB's competitors is 7.71, providing a benchmark for relative valuation. Assembly Biosciences Inc Corp (ASMB) exhibits a P/S ratio of 17.60, which is 128.33% above the industry average. Given its robust revenue growth of 57.62%, this premium appears sustainable.

What is the current P/B ratio for Assembly Biosciences Inc (ASMB) as of Mar 03 2026?

As of Mar 03 2026, Assembly Biosciences Inc (ASMB) has a P/B ratio of 2.92. This indicates that the market values ASMB at 2.92 times its book value.

What is the current FCF Yield for Assembly Biosciences Inc (ASMB) as of Mar 03 2026?

As of Mar 03 2026, Assembly Biosciences Inc (ASMB) has a FCF Yield of -10.45%. This means that for every dollar of Assembly Biosciences Inc's market capitalization, the company generates -10.45 cents in free cash flow.

What is the current Forward P/E ratio for Assembly Biosciences Inc (ASMB) as of Mar 03 2026?

As of Mar 03 2026, Assembly Biosciences Inc (ASMB) has a Forward P/E ratio of -15.92. This means the market is willing to pay $-15.92 for every dollar of Assembly Biosciences Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Assembly Biosciences Inc (ASMB) as of Mar 03 2026?

As of Mar 03 2026, Assembly Biosciences Inc (ASMB) has a Forward P/S ratio of 17.60. This means the market is valuing ASMB at $17.60 for every dollar of expected revenue over the next 12 months.

ASMB Valuation